Abstract
Organizational protein complexes at inhibitory postsynapses in the brain play a key role in regulating the flow of information through neuronal networks, and accordingly, abnormalities in these complexes can contribute to the pathophysiology of psychiatric disorders. Recent research indicates that the molecular composition of these complexes is highly diverse and synapse-specific, posing major challenges for basic research but also offering opportunities for potential clinical applications.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Literatur
Marín O (2012) Interneuron dysfunction in psychiatric disorders. Nat Rev Neurosci 13:107–120
Babaev O, Piletti Chatain C, Krueger-Burg D (2018) Inhibition in the amygdala anxiety circuitry. Exp Mol Med 50:18
Krueger-Burg D, Papadopoulos T, Brose N (2017) Organizers of inhibitory synapses come of age. Curr Opin Neurobiol 45:66–77
Poulopoulos A, Aramuni G, Meyer G et al. (2009) Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin. Neuron 63:628–642
Babaev O, Botta P, Meyer E et al. (2016) Neuroligin 2 deletion alters inhibitory synapse function and anxiety-associated neuronal activation in the amygdala. Neuropharmacology 100:56–65
Foldy C, Malenka RC, Sudhof TC (2013) Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabi-noid signaling. Neuron 78:498–509
Ehrlich I, Humeau Y, Grenier F et al. (2009) Amygdala inhibitory circuits and the control of fear memory. Neuron 62:757–771
Bandelow B, Michaelis S, Wedekind D (2017) Treatment of anxiety disorders. Dialogues Clin Neurosci 19:93–107
Babaev O, Cruces-Solis H, Piletti Chatain C et al. (2018) IgSF9b regulates anxiety behaviors through effects on centro-medial amygdala inhibitory synapses. Nat Commun 9:5400
Cruces-Solis H, Babaev O, Ali H et al. (2019) Altered theta/beta frequency synchrony links abnormal anxiety-related behaviors to synaptic inhibition in Neuroligin-2 knockout mice. BioRxiv, doi: 10.1101/726190
Author information
Authors and Affiliations
Corresponding author
Additional information
Dilja Krueger-Burg 1997–2001 Biochemiestudium an der Oxford University, UK. 2007 Promotion in Neurowissenschaften an der Yale University, New Haven, USA. 2007–2010 Postdoc am Massachusetts Institute of Technology, Cambridge, USA. 2010–2018 Postdoc und anschließend Projektgruppenleiterin am Max-Planck-Institut für Experimentelle Medizin in Göttingen. 2019 Habilitation in Biochemie, Universitätsmedizin Göttingen; dort seit 2019 Gruppenleiterin an der Klinik für Psychiatrie.
Rights and permissions
Open Access: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaption, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Open access funding provided by Max Planck Society.
About this article
Cite this article
Krueger-Burg, D. Proteinkomplexe an inhibitorischen Synapsen in psychiatrischen Störungen. Biospektrum 25, 722–724 (2019). https://doi.org/10.1007/s12268-019-0224-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12268-019-0224-x